- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04254003
Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses
March 17, 2020 updated by: Alcon Research
The purpose of this study is to evaluate the rotational behavior of DT1 Toric contact lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single visit, non-dispense study where subjects will be exposed to the test and control lenses for approximately 1 hour each.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Maitland, Florida, United States, 32751
- Alcon Investigative Site CT-11
-
-
Minnesota
-
Eden Prairie, Minnesota, United States, 55344
- Alcon Investigative Site CT-27
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Current wearer of any commercial soft daily wear contact lens with at least 3 months of wearing experience with a minimum wearing time of 5 days per week and 8 hours per day.
- Requiring contact lens (manifest refraction) of a cylindrical power of -0.75 to -2.50 diopter cylinder (DC).
- Best corrected distance visual acuity 20/25 or better Snellen in each eye (as determined by manifest refraction at screening).
- Willing to NOT use rewetting/lubricating drops at any time during the study. Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Any anterior segment infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the Investigator.
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the Investigator.
- History of refractive surgery or plan to have refractive surgery during the study or irregular cornea in either eye.
- Eye injury in either eye within 12 weeks immediately prior to enrollment for this trial.
Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Test, then Control
DT1 Toric contact lenses worn first, followed by AO1DfA contact lenses, as randomized.
Each product will be worn in both eyes for approximately 1 hour.
|
Delefilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)
Other Names:
Senofilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)
Other Names:
|
Other: Control, then Test
AO1DfA contact lenses worn first, followed by DT1 Toric contact lenses, as randomized.
Each product will be worn in both eyes for approximately 1 hour.
|
Delefilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)
Other Names:
Senofilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of DT1 toric lenses with axis orientation within ±30° from the intended axis, 10 min after lens insertion
Time Frame: Day 1, 10 minutes after lens insertion, each product
|
A slit lamp will be used to observe axis orientation.
|
Day 1, 10 minutes after lens insertion, each product
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 5, 2020
Primary Completion (Actual)
March 2, 2020
Study Completion (Actual)
March 2, 2020
Study Registration Dates
First Submitted
January 31, 2020
First Submitted That Met QC Criteria
February 3, 2020
First Posted (Actual)
February 5, 2020
Study Record Updates
Last Update Posted (Actual)
March 18, 2020
Last Update Submitted That Met QC Criteria
March 17, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLO870-C003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Errors
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Ohio State UniversityNational Eye Institute (NEI); University of HoustonCompleted
-
Coopervision, Inc.Completed
Clinical Trials on DT1 Toric contact lenses
-
University of Alabama at BirminghamAlcon ResearchCompleted
-
Coopervision, Inc.Completed
-
Alcon ResearchCompletedRefractive Error
-
Alcon ResearchCompletedRefractive Errors | AstigmatismUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedAstigmatism | Myopia | AmetropiaUnited States
-
CIBA VISIONCompletedRefractive Error | Astigmatism | Myopia
-
Alcon ResearchCompletedAstigmatismUnited States
-
Alcon ResearchCompletedRefractive Errors | Myopia | AmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States